Knowing the different types of breast cancer is a major asset in the fight against a disease that affects thousands of women across the Maghreb every year. Far from being a uniform condition, breast cancer comes in a variety of forms, each with its own characteristics, behaviour and treatment options. When properly understood, this diversity allows doctors to tailor treatments precisely and to improve the chances of recovery considerably.
Breast anatomy: understanding the terrain of the types of breast cancer
Structure of the mammary gland
To grasp the different types of breast cancer, you first need to understand breast anatomy. The breast is a complex gland made up of several components:
Each breast contains around twenty lobes, themselves composed of 15 to 20 lobules. These structures produce milk under the action of the sex hormones (progesterone and oestrogen). Their cyclical functioning explains certain variations observed in women.
These ducts carry milk from the lobules to the nipples. They are strategic areas where several types of breast cancer can develop, notably ductal carcinomas.
Made up of fat, blood and lymphatic vessels, along with elastic fibres, this tissue surrounds and protects the glandular structures. Its rich blood supply can facilitate the spread of certain types of breast cancer.
General classification of the types of breast cancer
Carcinomas versus other cancers
95% of breast cancers are carcinomas, which means they arise from epithelial cells (the cells forming the outer layer of organs). This overwhelming predominance warrants particular attention to this category.
According to the site of origin
The types of breast cancer are divided mainly according to where they arise:
- Lobular adenocarcinoma: the peripheral cells of the lobule are affected
- Ductal adenocarcinoma: the epithelial cells of the duct are affected
This fundamental distinction influences tumour behaviour and treatment strategies.
In situ types of breast cancer: the non-invasive forms
Ductal carcinoma in situ (DCIS)
DCIS is the most common non-invasive type of breast cancer. In our Maghreb countries, its detection is gradually increasing thanks to improvements in mammographic screening.
- Location: the milk ducts only
- Spread: no extension to neighbouring tissues
- Detection: generally asymptomatic, found by mammography
- Prognosis: excellent if treated appropriately
- Progression: may increase the risk of a later invasive cancer
Surgery with adequate safety margins remains necessary. In our regions, access to modern mammographic equipment makes early diagnosis of this type of breast cancer easier.
Lobular carcinoma in situ (LCIS)
Less common and often discovered by chance, LCIS particularly affects women aged 40 to 50 in our region.
- Diagnosis: rarely detectable clinically
- Discovery: during biopsies carried out for other reasons
- Monitoring: regular medical follow-up recommended
- Prognosis: many never cause any problems
Invasive types of breast cancer: the infiltrating forms
Invasive ductal carcinoma (IDC)
IDC is the most common type of breast cancer in our Maghreb countries. Recent data reveal characteristics specific to our region.
In Morocco, invasive ductal carcinoma accounts for 80.7% of cases according to data from the Mohammed VI Centre. In Tunisia, this proportion reaches 95.6% in the North-West region, while in Casablanca it stands at 73.2%.
- Average age: 51 years in Tunisia, 51.6 years in Morocco
- Average size: 29.3 mm in Tunisia (larger than in Europe)
- Grade: predominance of grade II (54-57% of cases)
- Lymph node involvement: 50.9% in Tunisia, 71.1% in Morocco
This type of breast cancer crosses the ductal wall to invade the surrounding breast tissue. This infiltration increases the risk of spread to:
- The axillary lymph nodes
- Distant organs (bones, liver, lungs, brain)
Invasive lobular carcinoma (ILC)
ILC is the second most common invasive type of breast cancer. In the Maghreb, it presents certain particularities.
- Frequency: 5 to 15% of breast cancers
- Average age: 53.43 years (Tunisia)
- Particularities: diagnosis is often later
- Multifocality: common (44.8% of cases in Tunisia)
- Palpation: often difficult to detect
- Mammography: may go unnoticed
- Bilaterality: more common than with IDC
- Progression: generally slower
Inflammatory breast cancer (IBC)
This particularly aggressive type of breast cancer deserves special attention in our region.
- Frequency: 1 to 3% of all types of breast cancer
- Population affected: young women and women of African descent more often
- Progression: very rapid and aggressive
- Symptoms: redness, swelling, no palpable lump
Tunisian data reveal a notable frequency of inflammatory breast carcinoma in the North-West region, probably linked to specific genetic and environmental factors.
Types of breast cancer according to molecular profile
Modern molecular classification
Analysis of hormone receptors and molecular markers reveals different subtypes with major implications for treatment.
Summary table of the molecular subtypes recorded in Morocco (Mohammed VI Centre), Casablanca and Tunisia:
| Subtype | Morocco (Mohammed VI Centre) | Casablanca | Tunisia |
|---|---|---|---|
| Luminal A | 41.4% of cases | 14.2% | — |
| Luminal B | 10.4% | 46% (more common) | Dominant subtype |
| Triple-negative | 11.4% | 15.3% | — |
| HER2-positive | 6.3% | 7.4% | Notable frequency (HER2 neu) |
Hormone-driven breast cancer (Luminal A and B)
These types of breast cancer express oestrogen and/or progesterone receptors.
- Prognosis: generally favourable
- Treatment: responds to hormone therapy
- Survival: high long-term rates
- Recurrence: lower risk
Recent studies suggest an ideal duration of adjuvant hormone therapy of seven years for high-risk women, adapting international recommendations to our populations.
HER2-positive breast cancer
This type of breast cancer over-expresses the HER2 receptor, offering specific therapeutic targets.
- Frequency: 15 to 20% of breast cancers
- Aggressiveness: often more aggressive tumours
- Targeted therapy: responds to anti-HER2 agents
- Prognosis: improved thanks to targeted treatments
Triple-negative breast cancer: a therapeutic challenge
Particularities in the Maghreb
Triple-negative cancer is a major issue in our region, with frequencies that vary from country to country.
- Frequency: 11.4% in Morocco, 15.3% in Casablanca
- Age: often affects young women
- Aggressiveness: high-grade tumours are common
- Prognosis: more guarded than for other types
The absence of hormone receptors and HER2 limits the treatment options:
- Hormone therapy: ineffective
- Anti-HER2 targeted therapies: of no use
- Chemotherapy: the mainstay of treatment
Recent therapeutic advances
Several innovative treatments are emerging for this difficult type of breast cancer:
- Trodelvy®: an antibody-chemotherapy combination
- Indications: metastatic triple-negative cancer
- Mechanism: specific targeting of cancer cells
- Keytruda®: in combination with chemotherapy
- Criteria: tumours expressing PD-L1
- Results: improved relapse-free survival (84.5% vs 76.8%)
- Olaparib: for BRCA1/2 mutations
- Efficacy: an 8% increase in relapse-free survival
- Target: women with a genetic predisposition
Prognostic factors according to the types of breast cancer
Histological grade (SBR classification)
Assessing the grade has a direct influence on prognosis:
- Grade I: 3.9% of cases (Morocco)
- Grade II: 54-57% (the majority in the region)
- Grade III: 31.9% (Morocco)
- Grade I: slow progression, good prognosis
- Grade II: moderate progression
- Grade III: high aggressiveness, close monitoring
Lymph node involvement
Involvement of the lymph nodes is a major prognostic factor:
- Tunisia: 50.9% lymph node involvement
- Morocco: 71.1% (Casablanca)
- Vascular emboli: 23.7-42.2% depending on the region
Tumour size
Size is a crucial prognostic element:
- Average size: 29.3 mm (larger than in Europe)
- Stages T1-T2: 73.6% of cases
- Stages T3-T4: 26.4% (a notable proportion of advanced forms)
Regional particularities of the types of breast cancer
Age of onset
The age at diagnosis shows particularities in our region:
- Median age: 51-51.6 years (earlier than in the West)
- Young women: 18.7% of patients under 40
- Implications: tumours are often more aggressive in younger women
Environmental factors
The adoption of a Western lifestyle influences the course of the types of breast cancer:
- Diet: the abandonment of traditional habits
- Sedentary living: rising physical inactivity
- Obesity: a growing risk factor
Access to care
Limited infrastructure influences diagnosis and treatment:
- Morocco: 6 oncology centres
- Algeria: 3 cancer-care centres
- Tunisia: 1 specialised institute
This distribution has a direct impact on the management of the different types of breast cancer.
The evolution of treatments according to type
A personalised approach
Modern medicine tailors treatments to the specific type of cancer:
- Conservative: favoured whenever possible
- Radical: 63.3% for ILC in Tunisia
- Reconstruction: growing range of options
- Frequency: 93.3% of patients (ILC, Tunisia)
- Techniques: gradual modernisation of equipment
- Access: a major challenge in certain regions
- Chemotherapy: tailored to the molecular subtype
- Hormone therapy: 70-80% of cases eligible
- Targeted therapies: increasingly developed
Genomic testing: the future of personalisation
Predictive markers
In-depth molecular analysis makes it possible to refine treatment decisions:
- Objective: to identify the women who will benefit from chemotherapy
- Threshold: a score below 25 to avoid chemotherapy
- Population: post-menopausal women
- Impact: a reduction in unnecessary treatments
Prospects for the future
The future of managing the types of breast cancer is moving towards:
- More sophisticated multigene tests
- Artificial intelligence for interpretation
- Precision medicine tailored to Maghreb populations
Prevention according to the types of breast cancer
General measures
Regardless of the type, certain preventive measures remain universal:
- Regular screening: mammography as recommended
- A healthy lifestyle: a Mediterranean diet, physical activity
- Weight control: maintaining a normal BMI
- Limiting alcohol: a modifiable risk factor
Enhanced monitoring
Certain types of breast cancer call for particular vigilance:
- LCIS: regular medical follow-up
- Family history: early, enhanced screening
- BRCA mutations: specialised monitoring
Future challenges for the types of breast cancer in the Maghreb
Improving diagnosis
The priorities include:
- Continuing medical training on the new types
- Modern equipment: wider availability of diagnostic tools
- Awareness-raising: educating the public about the diversity of cancers
Access to innovative treatments
The issues at stake concern:
- Targeted therapies: availability and accessibility
- Molecular tests: making analyses more widely available
- Specialised training: expertise in precision medicine
Regional research
Developing specific studies will make it possible to:
- Characterise the Maghreb types of breast cancer
- Identify the genetic factors specific to local populations
- Develop culturally appropriate therapeutic adaptations
Conclusion: towards a personalised approach to the types of breast cancer
The diversity of the types of breast cancer calls for a personalised, nuanced medical approach. In our Maghreb countries, this reality takes on a particular dimension, with specific epidemiological characteristics: an earlier age of onset, often larger tumour sizes, and a notable frequency of certain molecular subtypes.
This in-depth knowledge of the different types of breast cancer is a decisive asset in the fight against the disease. It allows medical teams to tailor diagnostic and therapeutic strategies precisely, to optimise the chances of recovery and to reduce unnecessary side effects.
The future is moving towards precision medicine, in which each type of breast cancer will benefit from bespoke care. Advances in molecular biology, targeted therapies and artificial intelligence are gradually transforming care, even in our regions where resources are sometimes limited.
For the women of the Maghreb, understanding this diversity of the types of breast cancer represents a form of power: the power to take an active part in treatment decisions, to ask the right questions and to approach their treatment with informed confidence. For behind every diagnosis lies a unique story, calling for a unique approach, tailored to the specific type of cancer at hand.
